261 related articles for article (PubMed ID: 19296675)
1. Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice.
Wang XL; Xu R; Wu X; Gillespie D; Jensen R; Lu ZR
Mol Pharm; 2009; 6(3):738-46. PubMed ID: 19296675
[TBL] [Abstract][Full Text] [Related]
2. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
Wang XL; Xu R; Lu ZR
J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
[TBL] [Abstract][Full Text] [Related]
3. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
4. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
6. Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles.
Kummitha CM; Malamas AS; Lu ZR
Int J Nanomedicine; 2012; 7():5205-14. PubMed ID: 23055731
[TBL] [Abstract][Full Text] [Related]
7. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
[TBL] [Abstract][Full Text] [Related]
8. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
9. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
[TBL] [Abstract][Full Text] [Related]
10. Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery.
Wang XL; Ramusovic S; Nguyen T; Lu ZR
Bioconjug Chem; 2007; 18(6):2169-77. PubMed ID: 17939730
[TBL] [Abstract][Full Text] [Related]
11. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.
Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y
J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Contrast Enhanced MRI Assessing the Antiangiogenic Effect of Silencing HIF-1α with Targeted Multifunctional ECO/siRNA Nanoparticles.
Malamas AS; Jin E; Gujrati M; Lu ZR
Mol Pharm; 2016 Jul; 13(7):2497-506. PubMed ID: 27264671
[TBL] [Abstract][Full Text] [Related]
14. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
Gujrati M; Vaidya A; Lu ZR
Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor.
Yuan ZQ; Chen WL; You BG; Liu Y; Yang SD; Li JZ; Zhu WJ; Zhou XF; Liu C; Zhang XN
J Control Release; 2017 Dec; 268():198-211. PubMed ID: 29061511
[TBL] [Abstract][Full Text] [Related]
17. Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo.
Gillespie DL; Whang K; Ragel BT; Flynn JR; Kelly DA; Jensen RL
Clin Cancer Res; 2007 Apr; 13(8):2441-8. PubMed ID: 17438103
[TBL] [Abstract][Full Text] [Related]
18. Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method.
Corbet C; Ragelle H; Pourcelle V; Vanvarenberg K; Marchand-Brynaert J; Préat V; Feron O
J Control Release; 2016 Feb; 223():53-63. PubMed ID: 26699426
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release.
Gujrati M; Malamas A; Shin T; Jin E; Sun Y; Lu ZR
Mol Pharm; 2014 Aug; 11(8):2734-44. PubMed ID: 25020033
[TBL] [Abstract][Full Text] [Related]
20. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
